A Reuters report (Aug 2025) interviewed multiple US doctors on GLP-1s: insurance coverage has tightened in 2025 as many employers drop it for the expensive GLP-1 drugs, said one physician ( [26] )
Timing matters: Inverted U-shaped efficacy of dose distribution in translational neuromodulation for treatment-resistant depression
In addition, rapid weight loss has been shown to trigger temporary shedding (telogen effluvium)
Some people stabilize at lower doses if they experience good appetite suppression, while others tolerate and benefit from higher amounts
Upper panel Baseline One week of continuous glucose monitor (CGM) result The panel above shows both glucose spikes and high basal glucose
Based on a comprehensive review of your medical history, lifestyle preferences, and insurance coverage, your Klinic provider will recommend the best fit for your needs